As a 40-year-old who lives with cystic fibrosis (CF), Zachary Schulz, PhD, EdS, MPH, is said to be among the reputed “last generation” of patients — those born before the advent of drugs that target ...

ROCHESTER, N.Y. (WROC) — On Wednesday, providers from Highland Hospital made another donation to support global efforts to treat cystic fibrosis. Cystic fibrosis is a genetic condition that causes ...

A 24-week phase 3 trial has found that once-daily vanzacaftor-tezacaftor-deutivacaftor is generally safe and well tolerated in children with cystic fibrosis aged 6-11 years. The treatment maintains ...

Alyftrek (vanzacaftor/tezacaftor/deutivacaftor) is a combination medicine approved by the FDA in 2024. Alyftrek is approved to treat people ages 6 and older who have ...

Cystic fibrosis (CF) is a rare autosomal recessive disorder that affects numerous systems of the body. It is a complicated disease that differs from person to person. An autosomal recessive disorder ...

Cystic fibrosis is a chronic genetic condition that causes thick, sticky mucus to build up in your lungs. This often leads to frequent respiratory infections and gastrointestinal (GI) problems. If you ...

Breathing disorders are common in the U.S. with conditions like COPD affecting some 7% of the population and asthma affecting ...